Differential influence of open surgery and sepsis on the circulating insulin-like growth factors and their binding proteins as representative metabolic markers

Clin Biochem. 2007 Oct;40(15):1122-8. doi: 10.1016/j.clinbiochem.2007.06.008. Epub 2007 Jul 5.

Abstract

Objectives: In critical illnesses and stress conditions many endocrine systems are disturbed. In the current study we determined the influence of open surgery, post-operative sepsis and its early therapy on the components of the insulin-like growth factor (IGF) system in patients with malignant gastric or pancreatic tumors.

Design and methods: Twenty-one patients and eighty-one age- and sex-matched healthy subjects were included in this study. IGF-I, IGF-II, IGF binding proteins (IGFBPs), cortisol, insulin and protein concentrations (total, albumin and IgG) were determined pre-operatively, post-operatively, when sepsis was diagnosed and 48 h after initiating therapy.

Results: The concentrations of circulating IGF-I, IGF-II and IGFBP-3 were significantly lower in pre-operative patients compared to healthy subjects. Sepsis caused a further decrease in IGF-I and IGFBP-3 but an increase in IGFBP-1, IGFBP-2 and IGFBP-4 resulting in a redistribution of IGF molecules from ternary to binary complexes.

Conclusions: The presence of malignant gastric or pancreatic tumors followed by post-operative sepsis caused a serious misbalance in components of the IGF system which failed to recover during the time of our longitudinal study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers / analysis
  • Case-Control Studies
  • Digestive System Surgical Procedures / adverse effects*
  • Female
  • Humans
  • Insulin-Like Growth Factor Binding Proteins / analysis*
  • Male
  • Middle Aged
  • Postoperative Complications / blood
  • Postoperative Complications / metabolism
  • Sepsis / blood*
  • Sepsis / diagnosis
  • Sepsis / etiology*
  • Sepsis / metabolism
  • Somatomedins / analysis*

Substances

  • Biomarkers
  • Insulin-Like Growth Factor Binding Proteins
  • Somatomedins